Evofem up 24% premarket on positive Amphora data in STD prevention [Seeking Alpha]
Evofem Biosciences, Inc. (EVFM)
Last evofem biosciences, inc. earnings: 3/12 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
evofem.com
Company Research
Source: Seeking Alpha
Seeking Alpha Healthcare | On the Move Evofem up 24% premarket on positive Amphora data in STD prevention Dec. 2, 2019 7:53 AM ET Evofem Biosciences, Inc. (EVFM) Douglas W. House Thinly traded micro cap Evofem Biosciences (NASDAQ: positive topline results AMPREVENCE The study met the primary and secondary endpoints with a favorable safety profile. Specifically, the chlamydia infection rate in the Amphora cohort was 4.9% (n=14/288) at month 4 compared to 9.8% (n=28/287) for placebo (p=0.024). The gonorrhea infection rate was 0.7% (n=2/280) versus 3.2% (n=9/277) for control (p=0.03). The company intends to submit the data for presentation at a future medical conference. An End-of-Phase 2 meeting with the FDA is next up. Management will host a conference call this morning at 8:30 am ET to discuss the results. See all stocks on the move » Now read: InMode: Not So Pretty Anymore » Try PREMIUM
Show less
Read more
Impact Snapshot
Event Time:
EVFM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVFM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVFM alerts
High impacting Evofem Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
EVFM
Sec Filings
- 3/28/24 - Form 8-K
- 3/27/24 - Form 10-K
- 3/27/24 - Form 8-K
- EVFM's page on the SEC website